Is Tamoxifen Alone a Viable Option for Women with Low-Risk DCIS Breast Cancer?

Now offering NEW extended store hours!
Monday - Friday: 9:00 AM to 7:00 PM
Saturday: 9:00 AM to 4:00 PM
Sunday: 9:00 AM - 2:00 PM
Text or call us at (973) 483-4749, Fax (973) 482-0643, or send an e-mail to info@lisspharmacy.com(973) 483-4749, Fax (973) 482-0643, or send an e-mail to info@lisspharmacy.com. Someone from our team will get back to you as soon as possible!

Posted December 16, 2025

In a new study, women with very early-stage DCIS breast cancer taking tamoxifen alone had higher recurrence rates than researchers expected. But they say the incidence of invasive breast cancer was still low at 5 years, suggesting tamoxifen alone may be an option in “carefully selected patients.”